PExATool
| Reference number | |
| Coordinator | GU VENTURES AB - GU HOLDING AB |
| Funding from Vinnova | SEK 2 000 000 |
| Project duration | May 2013 - December 2015 |
| Status | Completed |
Important results from the project
This project aimed to develop an appropriate and verified instrument that can be offered to customers, as a tool in research, or as a service to provide sample matrices of subjects in various studies. The project also aimed to package and validate the business concept containing instrument, including the manufacturing and sales process, software, installation, support, and IPR. The business model entails that PExA in a convincing way will reach out to identified customer groups. We believe that the project has been very successful and that we have achieved our goals.
Expected long term effects
The result is a verified and adapted instrument, PExA 2.0 that has been serial produced and in its final phase getting ready for an international launch in the research market. PExA 2.0 will be available for researchers seeking biomarkers to identify major lung diseases such as COPD and asthma. By using PExA´s instrument, researchers are given the opportunity to study patients´ various conditions in the early stages.
Approach and implementation
The work has been structured into four blocks, i.e. milestones; verification of the market, compile specifications, customizing the product and verify by means of users and customers. We felt that the priority of tasks was done in the correct sequence, which contributed to meeting the goals and objectives formulated for the project.